HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

Abstract:

:Amplification of HER-2 oncogene was analysed in DNAs obtained from 291 primary human mammary carcinomas. 52/291 (18%) were found to contain amplified HER-2 oncogene. Moderate amplification (2- to 5-fold) was noted in 36/291 (12%). Thirteen tumors (4.5%) had a copy number of 5 to 10. A 10- to 20-fold and greater than 20-fold amplification was observed in 2 and 1 patient, respectively. Sample sizes allowed the determination of estrogen receptor (ER) and progesterone receptor (PgR) levels in 253/291 primary breast cancers. HER-2 gene amplification was noted in 14% of ER+ patients and in 28% of ER- patients, respectively (P = 0.02). Similarly a significantly greater number of PgR- primary mammary carcinoma exhibited an amplification of the HER-2 gene compared to PgR+ cases (22% vs. 16%, P = 0.01). Although statistically not significant, tumors with HER-2 gene amplification were found to have lower levels of ER and PgR. No association of HER-2 amplification with the androgen receptor and EGF receptor was observed. Present data combine to suggest that tumor progression is more stringently controlled by the oncogene upon loss of hormone dependency. Differences found in HER-2 amplification between steroid receptor positive and negative tumors could be helpful to define a specific subset of women to whom adjuvant therapy should be directed.

journal_name

Oncogene

journal_title

Oncogene

authors

Zeillinger R,Kury F,Czerwenka K,Kubista E,Sliutz G,Knogler W,Huber J,Zielinski C,Reiner G,Jakesz R

subject

Has Abstract,Author List Incomplete

pub_date

1989-01-01 00:00:00

pages

109-14

issue

1

eissn

0950-9232

issn

1476-5594

journal_volume

4

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.

    abstract::Several small GTPases of the Ras superfamily have been shown to antagonize TGFbeta signaling in human tumor cell lines. Some of these GTPases are post-translationally modified by farnesylation, a lipid modification catalyzed by farnesyltransferase and required for the proteins to attach to membranes and to function. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203920

    authors: Adnane J,Bizouarn FA,Chen Z,Ohkanda J,Hamilton AD,Munoz-Antonia T,Sebti SM

    更新日期:2000-11-16 00:00:00

  • An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II.

    abstract::Myc promotes both normal cell proliferation and oncogenic transformation through the activation and repression of target genes. The c-Myc-S protein is a truncated form of c-Myc that is produced in some cells from translation initiation at an internal AUG codon. We report that c-Myc-S and a similar truncated form of N-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210734

    authors: Cowling VH,Cole MD

    更新日期:2008-02-21 00:00:00

  • Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.

    abstract::We have previously demonstrated the existence of a melanoma tumor suppressor gene(s) on the long arm of chromosome 11 through suppression of tumorigenicity assays. Although loss of heterozygosity studies also support this finding, only a large critical region (44 cM) has been identified to date on 11q22-25. To further...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202664

    authors: Robertson GP,Goldberg EK,Lugo TG,Fountain JW

    更新日期:1999-05-20 00:00:00

  • Nucleic acid targeting: towards personalized therapy for head and neck cancer.

    abstract::In light of a detailed characterization of genetic aberrations in cancer, nucleic acid targeting represents an attractive therapeutic approach with significant translational potential. Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer deaths worldwide with stagnant 5-year survival rates. Advan...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.424

    authors: Parsel SM,Grandis JR,Thomas SM

    更新日期:2016-06-23 00:00:00

  • Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.

    abstract::The human ret proto-oncogene (proto-ret), encoding a receptor tyrosine kinase, is highly expressed in neuroblastomas, medullary thyroid carcinomas (MTCs) and pheochromocytomas, which are all tumors of cells originating from the neural crest. In studies on the transcription mechanism of proto-ret, we identified the tra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Itoh F,Ishizaka Y,Tahira T,Yamamoto M,Miya A,Imai K,Yachi A,Takai S,Sugimura T,Nagao M

    更新日期:1992-06-01 00:00:00

  • Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.

    abstract::The functional inactivation of the tumor susceptibility gene tsg101 in mouse NIH3T3 cells leads to cell transformation and the formation of metastatic tumors in nude mice. We cloned, mapped and sequenced the mouse tsg101 gene and further identified a processed pseudogene that is 98% identical to the tsg101 cDNA. Based...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202529

    authors: Wagner KU,Dierisseau P,Rucker EB 3rd,Robinson GW,Hennighausen L

    更新日期:1998-11-26 00:00:00

  • Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.

    abstract::Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208325

    authors: May D,Itin A,Gal O,Kalinski H,Feinstein E,Keshet E

    更新日期:2005-02-03 00:00:00

  • Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.

    abstract::Initiation of DNA replication requires the function of MCM gene products, which participate in ensuring that DNA replication occurs only once in the cell cycle. Expression of all mammalian genes of the MCM family is induced by growth stimulation, unlike yeast, and the mRNA levels peak at G1/S boundary. In this study, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202544

    authors: Ohtani K,Iwanaga R,Nakamura M,Ikeda M,Yabuta N,Tsuruga H,Nojima H

    更新日期:1999-04-08 00:00:00

  • Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

    abstract::Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0902-7

    authors: Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

    更新日期:2020-10-01 00:00:00

  • PTEN functions as a melanoma tumor suppressor by promoting host immune response.

    abstract::Cancer cells acquire several traits that allow for their survival and progression, including the ability to evade the host immune response. However, the mechanisms by which cancer cells evade host immune responses remain largely elusive. Here we study the phenomena of immune evasion in malignant melanoma cells. We fin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.409

    authors: Dong Y,Richards JA,Gupta R,Aung PP,Emley A,Kluger Y,Dogra SK,Mahalingam M,Wajapeyee N

    更新日期:2014-09-18 00:00:00

  • Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway.

    abstract::Tuftelin1 (TUFT1), an acidic protein constituent of developing and mineralizing tooth tissues, is regulated by hypoxia and the Hedgehog signaling pathway. We investigated the role of TUFT1 in hepatocellular carcinoma (HCC). qRT-PCR, immunohistochemistry and western blot were employed to evaluate TUFT1 level in HCC. MT...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0505-8

    authors: Dou C,Zhou Z,Xu Q,Liu Z,Zeng Y,Wang Y,Li Q,Wang L,Yang W,Liu Q,Tu K

    更新日期:2019-02-01 00:00:00

  • Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.

    abstract::Loss of von Hippel Lindau (VHL) protein function is a key driver of VHL diseases, including sporadic and inherited clear cell renal cell carcinoma. Modulation of the proteostasis of VHL, especially missense point-mutated VHL, is a promising approach to augmenting VHL levels and function. VHL proteostasis is regulated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.40

    authors: German P,Bai S,Liu XD,Sun M,Zhou L,Kalra S,Zhang X,Minelli R,Scott KL,Mills GB,Jonasch E,Ding Z

    更新日期:2016-09-22 00:00:00

  • Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.

    abstract::The mechanisms by which the p53 tumour suppressor protein would, in vivo, co-ordinate the adaptive response to genotoxic stress is poorly understood. p53 has been shown to transactivate several genes that could be involved in two main cellular responses, growth arrest and apoptosis. To get further insight into the tis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203366

    authors: Bouvard V,Zaitchouk T,Vacher M,Duthu A,Canivet M,Choisy-Rossi C,Nieruchalski M,May E

    更新日期:2000-02-03 00:00:00

  • Molecular pathology in basal cell cancer with p53 as a genetic marker.

    abstract::Human basal cell cancer (BCC) has unique growth characteristics with virtual inability to metastasize. We investigated clonality and genetic progression using p53 mutations as marker. Sampling was done through microdissection of frozen immunohistochemically stained 16 microm slices of tumors. From 11 BCC tumors 78 sam...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201435

    authors: Pontén F,Berg C,Ahmadian A,Ren ZP,Nistér M,Lundeberg J,Uhlén M,Pontén J

    更新日期:1997-08-28 00:00:00

  • mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.

    abstract::Cancer cells harboring oncogenic BRaf mutants, but not oncogenic KRas mutants, are sensitive to MEK inhibitors (MEKi). The mechanism underlying the intrinsic resistance to MEKi in KRas-mutant cells is under intensive investigation. Here, we pursued this mechanism by live imaging of extracellular signal-regulated kinas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.16

    authors: Komatsu N,Fujita Y,Matsuda M,Aoki K

    更新日期:2015-11-05 00:00:00

  • Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha.

    abstract::A previous report demonstrated that AP-2alpha favors the survival of ovarian cancer patients by clinical findings. However, the functional roles of AP-2alpha in human ovarian cancers have not been determined. To clarify the roles, we overexpressed AP-2alpha in SKOV3 human ovarian cancer cells, which originally possess...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207723

    authors: Sumigama S,Ito T,Kajiyama H,Shibata K,Tamakoshi K,Kikkawa F,Williams T,Tainsky MA,Nomura S,Mizutani S

    更新日期:2004-07-15 00:00:00

  • Dolichol-phosphate-mannose-3 (DPM3)/prostin-1 is a novel phospholipase C-gamma regulated gene negatively associated with prostate tumor invasion.

    abstract::The most ominous development in tumor progression is the transition to an invasive and metastatic phenotype. Little is known, however, about the molecular alterations that cause a tumor to become invasive. In view of this, we have used microarray expression analysis to evaluate the expression profiles of a unique pane...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204379

    authors: Manos EJ,Kim ML,Kassis J,Chang PY,Wells A,Jones DA

    更新日期:2001-05-17 00:00:00

  • The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix.

    abstract::The cellular transcription factor Brn-3a differentially regulates different human papilloma virus (HPV)-16 variants that are associated with different risks of progression to cervical carcinoma in infected humans. The upstream regulatory regions (URRs) of high- and intermediate-risk HPV-16 variants are activated by th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.33

    authors: Ndisang D,Khan A,Lorenzato F,Sindos M,Singer A,Latchman DS

    更新日期:2010-05-06 00:00:00

  • Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.

    abstract::The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61% of coding region, in germline DNA from 70 Italian breast and/o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: De Benedetti VM,Radice P,Mondini P,Spatti G,Conti A,Illeni MT,Caligo MA,Cipollini G,Bevilaqua G,Pilotti S,Pierotti MA

    更新日期:1996-09-19 00:00:00

  • Activation of p53 by roscovitine-mediated suppression of MDM2 expression.

    abstract::The p53 tumor suppressor is regulated by the MDM2 oncoprotein. Overexpression of MDM2 maintains p53 at low levels and contributes to the functional inactivation of p53 in a subset of tumors. We found that treatment with roscovitine and olomoucin, which were originally developed as cyclin-dependent kinase (CDK) inhibit...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204412

    authors: Lu W,Chen L,Peng Y,Chen J

    更新日期:2001-05-31 00:00:00

  • MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.

    abstract::Oncogenic RAS promotes production of reactive oxygen species (ROS), which mediate pro-malignant signaling but can also trigger DNA damage-induced tumor suppression. Thus RAS-driven tumor cells require redox-protective mechanisms to mitigate the damaging aspects of ROS. Here, we show that MutT Homolog 1 (MTH1), the mam...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.195

    authors: Patel A,Burton DG,Halvorsen K,Balkan W,Reiner T,Perez-Stable C,Cohen A,Munoz A,Giribaldi MG,Singh S,Robbins DJ,Nguyen DM,Rai P

    更新日期:2015-05-14 00:00:00

  • Effects of methylation on expression of TMS1/ASC in human breast cancer cells.

    abstract::Gene silencing associated with aberrant methylation of promoter region CpG islands is one mechanism in which tumor suppressor genes are inactivated in human cancers. Recently, we identified a novel gene, Target of Methylation-associated Silencing-1 (TMS1) (also called ASC), which is aberrantly methylated and silenced ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206430

    authors: Levine JJ,Stimson-Crider KM,Vertino PM

    更新日期:2003-05-29 00:00:00

  • Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.

    abstract::Early growth response-1 (Egr-1) is overexpressed in human prostate tumors and contributes to cancer progression. On the other hand, mutation of p53 is associated with advanced prostate cancer, as well as with metastasis and hormone independence. This study shows that in prostate cell lines in culture, Egr-1 overexpres...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.24

    authors: Sauer L,Gitenay D,Vo C,Baron VT

    更新日期:2010-05-06 00:00:00

  • NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

    abstract::Melanoma dedifferentiation, characterized by the loss of MITF and MITF regulated genes and by upregulation of stemness markers as CD271, is implicated in resistance to chemotherapy, target therapy and immunotherapy. The identification of intrinsic mechanisms fostering melanoma dedifferentiation may provide actionable ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.355

    authors: Perotti V,Baldassari P,Molla A,Vegetti C,Bersani I,Maurichi A,Santinami M,Anichini A,Mortarini R

    更新日期:2016-06-02 00:00:00

  • Sequential expression of the MAD family of transcriptional repressors during differentiation and development.

    abstract::Members of the Myc proto-oncogene family encode transcription factors that function in multiple aspects of cell behavior, including proliferation, differentiation, transformation and apoptosis. Recent studies have shown that MYC activities are modulated by a network of nuclear bHLH-Zip proteins. The MAX protein is at ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201611

    authors: Quéva C,Hurlin PJ,Foley KP,Eisenman RN

    更新日期:1998-02-26 00:00:00

  • Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress.

    abstract::The p21WAF1/CIP1/SDI1 gene is an important regulator of crucial cellular processes, including cell cycle control, cellular differentiation, and the response to genotoxic stress. Induction of p21 gene expression upon DNA damage is widely believed to be p53-dependent. In the present study we analysed the expression of p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201995

    authors: Butz K,Geisen C,Ullmann A,Zentgraf H,Hoppe-Seyler F

    更新日期:1998-08-13 00:00:00

  • Nerve growth factor induced stimulation of Ras requires Trk interaction with Shc but does not involve phosphoinositide 3-OH kinase.

    abstract::The TrkA receptor protein tyrosine kinase is involved in signalling PC12 cell differentiation and cessation of cell division in response to nerve growth factor (NGF). To assess the importance of adaptor proteins and Ras in NGF control of phosphoinositide 3-OH kinase (PI 3-kinase), specific receptor mutations in Trk ha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201980

    authors: Hallberg B,Ashcroft M,Loeb DM,Kaplan DR,Downward J

    更新日期:1998-08-13 00:00:00

  • MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.

    abstract::Ewing sarcoma is a pediatric bone tumor characterized in 85% of cases by the fusion between EWS and FLI1 genes that results in the expression of the EWS-FLI1 aberrant transcription factor. Histologically, the Ewing tumor expresses high levels of the CD99 membrane glycoprotein. It has been recently described that CD99 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.403

    authors: Franzetti GA,Laud-Duval K,Bellanger D,Stern MH,Sastre-Garau X,Delattre O

    更新日期:2013-08-15 00:00:00

  • Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.

    abstract::We have recently developed an allele titration assay (ATA) to assess the sensitivity and influence of normal cell admixture in loss of heterozygosity (LOH) studies based on CA-repeat. The assay showed that these studies are biased by the size-dependent differential sensitivity of allele detection. Based on these data,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203449

    authors: Alimov A,Kost-Alimova M,Liu J,Li C,Bergerheim U,Imreh S,Klein G,Zabarovsky ER

    更新日期:2000-03-09 00:00:00

  • Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.

    abstract::The hyperactivated Wnt/β-catenin signaling acts as a switch to induce epithelial to mesenchymal transition and promote colorectal cancer. However, due to its essential role in gut homeostasis, therapeutic targeting of this pathway has proven challenging. Additionally, IL-6/Stat-3 signaling, activated by microbial tran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.259

    authors: Ahmad R,Kumar B,Chen Z,Chen X,Müller D,Lele SM,Washington MK,Batra SK,Dhawan P,Singh AB

    更新日期:2017-11-23 00:00:00